Private Wealth Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Private Wealth Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$199K	Hold	401	–	–	0.02%	263
2026 Q1	$179K	Sell	401 -1	-0.2%	-$466	0.02%	271
2025 Q4	$182K	Hold	402	–	–	0.02%	270
2025 Q3	$157K	Sell	402 -85	-17%	-$35.5K	0.02%	264
2025 Q2	$217K	Buy	487 +9	+2%	+$4.15K	0.03%	229
2025 Q1	$232K	Buy	+478	New	+$223K	0.03%	210

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Private Wealth Asset Management's VRTX Position: Q2 2026 in Review

Private Wealth Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 401 shares worth $199K. The position accounts for 0.02% of the portfolio, ranked #263.

Private Wealth Asset Management first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $232K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Private Wealth Asset Management held 401 shares of Vertex Pharmaceuticals worth $199K as of Q2 2026.
Private Wealth Asset Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.02% of Private Wealth Asset Management's portfolio in Q2 2026, its #263 holding.
Private Wealth Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Private Wealth Asset Management's Vertex Pharmaceuticals position peaked at $232K in Q1 2025.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.